|
Index of reports
> Life Threatening Events (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytoxan (Cyclophosphamide) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cytoxan side effects in male
Reported by a physician from Ireland on 2012-06-25
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Confusional State, Aphasia, Urinary Incontinence, Hemiparesis, Cerebrovascular Accident, Multi-Organ Failure, Dysarthria, Respiratory Failure, Nervous System Disorder, Asthenia, Progressive Multifocal Leukoencephalopathy, Decreased Appetite
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Colchicine
Indication: Product Used FOR Unknown Indication
Cytoxan
Administration route: Oral
Indication: Rheumatoid Vasculitis
Remicade
Indication: Rheumatoid Arthritis
End date: 2007-08-01
Cytoxan
Administration route: Oral
End date: 2007-08-01
Prednisone
Indication: Vasculitis
Prednisone
Remicade
Indication: Vasculitis
End date: 2007-08-01
Plaquenil
Indication: Product Used FOR Unknown Indication
Plaquenil
Other drugs received by patient: Flecainide Acetate; Atenolol; Lasix; Theo-DUR; Aspirin; Hytrin; Restoril; Potassium Acetate
Possible Cytoxan side effects in 61 year old female
Reported by a physician from United States on 2012-06-07
Patient: 61 year old female
Reactions: Acute Lymphocytic Leukaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer
Start date: 2000-01-01
End date: 2002-01-01
Cytoxan
Indication: Breast Cancer
Start date: 2000-01-01
Taxol
Indication: Breast Cancer
Start date: 2000-01-01
End date: 2002-01-01
Adriamycin PFS
Indication: Breast Cancer
Start date: 2000-01-01
Possible Cytoxan side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-25
Patient: male, weighing 21.3 kg (46.9 pounds)
Reactions: B-Cell Lymphoma, Hypotension, Alanine Aminotransferase Increased, Pancytopenia, Roseolovirus Test Positive, Aspartate Aminotransferase Increased, Venoocclusive Liver Disease, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Mesna
Indication: Product Used FOR Unknown Indication
Fludarabine Phosphate
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B-Cell Lymphoma
Start date: 2011-12-27
End date: 2012-01-06
Cytoxan
Indication: Product Used FOR Unknown Indication
Possible Cytoxan side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-17
Patient: female
Reactions: Embolism
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Nolvadex
Administration route: Oral
Indication: Breast Cancer
Start date: 2000-12-05
Taxol
Indication: Breast Cancer
Herceptin
Dosage: maintenance dose over 30 mins, for 51 weeks
Adriamycin PFS
Indication: Breast Cancer
Start date: 2000-12-05
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Cytoxan
Indication: Breast Cancer
Start date: 2000-12-05
Possible Cytoxan side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-29
Patient: 54 year old male, weighing 119.0 kg (261.8 pounds)
Reactions: Nasopharyngitis, Lung Infection, Pulmonary Embolism, Oropharyngeal Pain, Cardio-Respiratory Arrest, Acute Respiratory Distress Syndrome, Septic Shock, Respiratory Syncytial Virus Test Positive, Infusion Related Reaction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytoxan
Dosage: 1404 mg on d1 c1-6, wks, 1,5,9,13, 17 and 21, intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-03-14
End date: 2011-08-02
Rituximab
Dosage: 100 mg mwf cycle 1, then 878 mg d1 cycle 206
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-03-14
End date: 2011-08-02
Pentostatin
Dosage: 9.36 mg on day 1 c1-6, intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-03-24
End date: 2011-08-02
Campath
Dosage: 30 mg, tiw x 4 weeks, subcutaneous
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-31
End date: 2011-11-25
Other drugs received by patient: Acyclovir; Bactrim DS
Possible Cytoxan side effects in 74 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-26
Patient: 74 year old male, weighing 81.2 kg (178.6 pounds)
Reactions: Excoriation, Anaemia, Hypotension, Neutropenic Sepsis, Tachycardia, Mental Status Changes, Atrial Fibrillation, Pyrexia, Fall, Cardiac Failure, Diarrhoea, Neutropenia, Cardiac Arrest, Lethargy, Cough
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisone
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-15
Lasix
Indication: Cardiac Disorder
End date: 2012-02-22
Matulane
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-15
Spironolactone
Indication: Cardiac Disorder
End date: 2012-02-22
Coreg
Indication: Cardiac Disorder
End date: 2012-02-22
Cytoxan
Start date: 2012-02-09
End date: 2012-02-16
Lisinopril
Indication: Cardiac Disorder
End date: 2012-02-22
Vinblastine Sulfate
Start date: 2012-02-09
End date: 2012-02-16
Other drugs received by patient: Levofloxacin; Prevacid; Tamsulosin HCL; Klor-CON; Folic Acid; Multi-Vitamins; Bleomycin Sulfate; Dacarbazine; Lidocaine; Zofran; Doxorubicin HCL
Possible Cytoxan side effects in 74 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-08
Patient: 74 year old male, weighing 81.2 kg (178.6 pounds)
Reactions: Confusional State, Excoriation, Anaemia, Neutropenic Sepsis, Atrial Fibrillation, Condition Aggravated, Mental Status Changes, Fall, Diarrhoea, Cardiac Failure, Cardiac Arrest, Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Matulane
Dosage: 200 mg; qd; po
Administration route: Oral
Indication: Hodgkin's Disease Nodular Sclerosis Stage Unspecified
Start date: 2012-02-02
End date: 2012-02-15
Cytoxan
Dosage: 1.186 mg;qw; iv
Indication: Hodgkin's Disease Nodular Sclerosis Stage Unspecified
Start date: 2012-02-09
End date: 2012-02-16
Lisinopril
Indication: Cardiac Disorder
End date: 2012-02-22
Coreg
Indication: Cardiac Disorder
End date: 2012-02-22
Prednisone TAB
Dosage: 80 mg; qd; po
Administration route: Oral
Indication: Hodgkin's Disease Nodular Sclerosis Stage Unspecified
Start date: 2012-02-02
End date: 2012-02-15
Vinblastine Sulfate
Dosage: 12 mg;qw; iv
Indication: Hodgkin's Disease Nodular Sclerosis Stage Unspecified
Start date: 2012-02-09
End date: 2012-02-16
Lasix
Indication: Cardiac Disorder
End date: 2012-02-22
Spironolactone
Indication: Cardiac Disorder
End date: 2012-02-22
Other drugs received by patient: Klor-CON; Doxorubicin HCL; Centrum Silver / 01292501 /; Tamsulosin HCL; Folic Acid; Lidocaine; Zofran; Levofloxacin; Prevacid; Bleomycin Sulfate; Dacarbazine
Possible Cytoxan side effects in male
Reported by a physician from Ireland on 2012-01-27
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Confusional State, Urinary Incontinence, Aphasia, Hemiparesis, Cerebrovascular Accident, Dysarthria, Multi-Organ Failure, Respiratory Failure, Nervous System Disorder, Asthenia, Progressive Multifocal Leukoencephalopathy, Decreased Appetite
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytoxan
Administration route: Oral
Indication: Rheumatoid Vasculitis
Prednisone
Indication: Vasculitis
Cytoxan
Administration route: Oral
End date: 2007-08-01
Plaquenil
Remicade
Indication: Vasculitis
End date: 2007-08-01
Plaquenil
Indication: Product Used FOR Unknown Indication
Colchicine
Indication: Product Used FOR Unknown Indication
Remicade
Indication: Rheumatoid Arthritis
End date: 2007-08-01
Prednisone
Other drugs received by patient: Atenolol; Potassium Chloride; Theo-DUR; Hytrin; Aspirin; Lasix; Restoril; Flecainide Acetate
Possible Cytoxan side effects in 65 year old female
Reported by a consumer/non-health professional from United States on 2012-01-24
Patient: 65 year old female, weighing 59.0 kg (129.7 pounds)
Reactions: Stem Cell Transplant, Myelodysplastic Syndrome, Complications of Transplant Surgery, Treatment Related Secondary Malignancy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytoxan
Other drugs received by patient: Possibly Other Chemo Drugs
|
